Paper25580906
Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents.
Papadopoulou MV and 8 others. J Med Chem, 2015. Cited by 50 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents. Papers, record 25580906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25580906
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amides | Major topic |
| Chagas Disease | Major topic |
| Methanol | Major topic |
| Triazoles | Major topic |
| Trypanocidal Agents | Major topic |
| Trypanosoma brucei rhodesiense | Major topic |
| Trypanosoma cruzi | Major topic |
| Animals | |
| Cell Line | |
| Dose-Response Relationship, Drug | |
| Mice | |
| Mice, Inbred BALB C | |
| Molecular Structure | |
| Parasitic Sensitivity Tests | |
| Rats | |
| Structure-Activity Relationship |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 GM067871 | NIGMS NIH HHS | United States | R01GM067871 | PubMed and NIH |
| GM067871 | NIGMS NIH HHS | United States | R01GM067871 | PubMed and NIH |
Source NIH RePORTER
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19753490 | Ergosterol biosynthesis and drug development for Chagas disease. | Mem Inst Oswaldo Cruz | 2009 | https://conductscience.org/library/papers/19753490 | PubMed |
| 2 | 23448316 | Antitrypanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth. | J Med Chem | 2013 | https://conductscience.org/library/papers/23448316 | PubMed |
| 3 | 18022567 | Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth. | Chem Biol | 2007 | https://conductscience.org/library/papers/18022567 | PubMed |
| 4 | 20399979 | Chagas disease. | Lancet | 2010 | https://conductscience.org/library/papers/20399979 | PubMed |
| 5 | 20530488 | Structural insights into inhibition of sterol 14alpha-demethylase in the human pathogen Trypanosoma cruzi. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20530488 | PubMed |
| 6 | 23372180 | VNI cures acute and chronic experimental Chagas disease. | J Infect Dis | 2013 | https://conductscience.org/library/papers/23372180 | PubMed |
| 7 | 22023653 | Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents. | J Med Chem | 2011 | https://conductscience.org/library/papers/22023653 | PubMed |
| 8 | 18769951 | CYP51: A major drug target in the cytochrome P450 superfamily. | Lipids | 2008 | https://conductscience.org/library/papers/18769951 | PubMed |
| 9 | 22550999 | Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents. | J Med Chem | 2012 | https://conductscience.org/library/papers/22550999 | PubMed |
| 10 | 7479555 | Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans. | Pharm Res | 1995 | https://conductscience.org/library/papers/7479555 | PubMed |
| 11 | 22948871 | Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22948871 | PubMed |
| 12 | 23504044 | CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds. | Int J Parasitol Drugs Drug Resist | 2012 | https://conductscience.org/library/papers/23504044 | PubMed |
| 13 | 24012457 | Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents. | Bioorg Med Chem | 2013 | https://conductscience.org/library/papers/24012457 | PubMed |
| 14 | 21912715 | Activity in vivo of anti-Trypanosoma cruzi compounds selected from a high throughput screening. | PLoS Negl Trop Dis | 2011 | https://conductscience.org/library/papers/21912715 | PubMed |
| 15 | 20028822 | Exploiting the drug-activating properties of a novel trypanosomal nitroreductase. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20028822 | PubMed |
| 16 | 18367671 | A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18367671 | PubMed |
| 17 | 24144412 | Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies. | Future Med Chem | 2013 | https://conductscience.org/library/papers/24144412 | PubMed |
| 18 | 23916507 | Evaluating the developmental toxicity of trypanocidal nitroaromatic compounds on zebrafish. | Acta Trop | 2013 | https://conductscience.org/library/papers/23916507 | PubMed |
| 19 | 20161970 | Inhibitory activity of marine sponge-derived natural products against parasitic protozoa. | Mar Drugs | 2010 | https://conductscience.org/library/papers/20161970 | PubMed |
| 20 | 21093499 | Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6. | Mol Biochem Parasitol | 2011 | https://conductscience.org/library/papers/21093499 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41976152 | Biphenyl as a Privileged Structure in Medicinal Chemistry: Advances in Anti-Infective Drug Discovery. | Molecules | 2026 | https://conductscience.org/library/papers/41976152 | PubMed |
| 38930921 | Fluconazole Analogs and Derivatives: An Overview of Synthesis, Chemical Transformations, and Biological Activity. | Molecules | 2024 | https://conductscience.org/library/papers/38930921 | PubMed |
| 38005183 | Anti-Trypanosoma cruzi Activity, Mutagenicity, Hepatocytotoxicity and Nitroreductase Enzyme Evaluation of 3-Nitrotriazole, 2-Nitroimidazole and Triazole Derivatives. | Molecules | 2023 | https://conductscience.org/library/papers/38005183 | PubMed |
| 34299579 | Chromenol Derivatives as Novel Antifungal Agents: Synthesis, In Silico and In Vitro Evaluation. | Molecules | 2021 | https://conductscience.org/library/papers/34299579 | PubMed |
| 32771798 | An insight on medicinal attributes of 1,2,4-triazoles. | Eur J Med Chem | 2020 | https://conductscience.org/library/papers/32771798 | PubMed |
| 32557280 | Planning new Trypanosoma cruzi CYP51 inhibitors using QSAR studies. | Mol Divers | 2021 | https://conductscience.org/library/papers/32557280 | PubMed |
| 32550995 | Construction and Evaluation of Molecular Models: Guide and Design of Novel SE Inhibitors. | ACS Med Chem Lett | 2020 | https://conductscience.org/library/papers/32550995 | PubMed |
| 32542530 | Fluconazole analogues with metal-binding motifs impact metal-dependent processes and demonstrate antifungal activity in Candida albicans. | J Biol Inorg Chem | 2020 | https://conductscience.org/library/papers/32542530 | PubMed |
| 31862616 | Current trends in the pharmacological management of Chagas disease. | Int J Parasitol Drugs Drug Resist | 2020 | https://conductscience.org/library/papers/31862616 | PubMed |
| 31427977 | Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31427977 | PubMed |
| 31181717 | Quantitative Structure-Activity Relationships for Structurally Diverse Chemotypes Having Anti-Trypanosoma cruzi Activity. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31181717 | PubMed |
| 29488127 | Combined Strategies to Improve the Expression of Recombinant Sterol C24-Methyltransferase from Leishmania braziliensis in E. coli. | Mol Biotechnol | 2018 | https://conductscience.org/library/papers/29488127 | PubMed |
| 28242662 | Nitrotriazole-Based Compounds as Antichagasic Agents in a Long-Treatment In Vivo Assay. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28242662 | PubMed |
| 27543881 | Nitrotriazole-based acetamides and propanamides with broad spectrum antitrypanosomal activity. | Eur J Med Chem | 2016 | https://conductscience.org/library/papers/27543881 | PubMed |
| 27139467 | Quinolone Amides as Antitrypanosomal Lead Compounds with In Vivo Activity. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27139467 | PubMed |
| 27092415 | Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds. | Eur J Med Chem | 2016 | https://conductscience.org/library/papers/27092415 | PubMed |
| 26643331 | Clinical Candidate VT-1161's Antiparasitic Effect In Vitro, Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex with the Target Enzyme CYP51 from Trypanosoma cruzi. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/26643331 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25580906
GET https://conductscience.org/api/papers/v1/25580906/references?page=2